Last Updated : July 6, 2022
Details
FilesProject Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Summary of Abstracts
Project Number:
RB1621-000
Question
- What are the benefits and harms of Infliximab for graft-versus-host disease?
Key Message
Three non-randomized studies were found about the benefits and harms of Infliximab for graft-versus-host disease.
Files
Last Updated : July 6, 2022